Phase
Condition
Peripheral Arterial Occlusive Disease
Treatment
GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX)
Clinical Study ID
Ages 18-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient treated with covered endovascular reconstruction of the aortic bifurcation (CERAB) procedure for aortoiliac occlusive disease (AIOD).
Patient was implanted with the VBX Device in the aortic position during a CERABprocedure.
Patient was treated with the CERAB procedure a minimum of 1 year before enrollmentdate.
Age ≥18 years at the time of CERAB procedure.
Obtain patient informed consent or waiver according to local Institutional ReviewBoard (IRB)/Ethics Committee (EC) -
Exclusion
Exclusion Criteria:
Patient with prior stenting in the aortic or common iliac artery at the time ofCERAB procedure.
Patient treated with concomitant chimney procedure at time of CERAB procedure (e.g.,inferior mesenteric artery, renal artery).
Participation in another drug or device investigational study at the time of theCERAB procedure date that can confound the study endpoints.
Study Design
Study Description
Connect with a study center
Azienda Ospedaliero-Universitaria di Padova
Padova, 35131
ItalySite Not Available
University of California
Fresno, California 93721
United StatesSite Not Available
Cooper University Hospital
Camden, New Jersey 08103
United StatesActive - Recruiting
Research Foundation SUNY Buffalo
Buffalo, New York 14203
United StatesActive - Recruiting
Mount Sinai Medical Center
New York, New York 10029
United StatesActive - Recruiting
Marshfield Hospital
Marshfield, Wisconsin 54449
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.